Endonuclease-G and the pathways to dopaminergic neurodegeneration: a question of location?

EMBO J. 2013 Nov 27;32(23):3014-6. doi: 10.1038/emboj.2013.238. Epub 2013 Oct 25.

Abstract

EMBO J (2013) 32 23, 3041–3054 ; DOI: 10.1038/emboj.2013.228; published online October 15 2013

Parkinson’s disease (PD) is characterised by the loss of dopaminergic neurons in the substantia nigra and accumulation of pathological inclusions containing α-synuclein termed Lewy bodies. However, to date the precise function of α-synuclein has remained elusive along with the mechanism of neuronal death. A paper published in this issue of EMBO Journal provides insight into the mechanism of α-synuclein-induced neuronal death and thereby reveals potential new targets for therapeutic intervention. Büttner et al (2013) highlight Endonuclease-G as a key executioner in α-synuclein toxicity and show that inhibiting mitochondrial release of Endonuclease-G can protect against α-synuclein toxicity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Apoptosis*
  • Endodeoxyribonucleases / metabolism*
  • Humans
  • Neuroblastoma / pathology*
  • Neurons / metabolism*
  • Parkinson Disease / pathology*
  • Substantia Nigra / pathology*
  • alpha-Synuclein / metabolism*

Substances

  • alpha-Synuclein
  • Endodeoxyribonucleases
  • endonuclease G